Reply to letter to the editor: Elevated fibroblast growth factor-23 and risk for cardiovascular disease or mortality in the general population.
Institute of Molecular Biology & Translational Medicine, The Affiliated People's Hospital, Jiangsu University, Zhenjiang, Jiangsu 212002, China.
Menglin
M
Jiang
Institute of Molecular Biology & Translational Medicine, The Affiliated People's Hospital, Jiangsu University, Zhenjiang, Jiangsu 212002, China.
Dandan
D
Gong
Institute of Molecular Biology & Translational Medicine, The Affiliated People's Hospital, Jiangsu University, Zhenjiang, Jiangsu 212002, China. Electronic address: jszjfanyu@163.com.
Yu
Y
Fan
D002318:Cardiovascular Diseases / Q000453:epidemiology*; D005346:Fibroblast Growth Factors; D006801:Humans; D012306:Risk
D005346:Fibroblast Growth Factors
Cardiovascular outcomes; Fibroblast growth factor-23; Meta-analysis; Mortality